HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹33 Cr | ₹30 Cr | ₹33 Cr | ₹36 Cr | ₹38 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of HIKAL ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹38 Cr |
How is Deferred Tax Assets / Liabilities of HIKAL Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | 8.33 | |
| Mar2024 | ₹30 Cr | -8.30 | |
| Mar2023 | ₹33 Cr | -10.14 | |
| Mar2022 | ₹36 Cr | -3.13 | |
| Mar2021 | ₹38 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,339.6 Cr | -2.3% | -2.4% | -49.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,933.0 Cr | -1.2% | -2.3% | 5.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | -1% | -0.9% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,549.0 Cr | -1.3% | 1.4% | 38.1% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | -0.1% | 4.8% | -6.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,652.0 Cr | -2.8% | -0.3% | 1.2% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -2.3% |
-2.4% |
-49.4% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses